207
Views
10
CrossRef citations to date
0
Altmetric
Articles

Fate of GdF3 nanoparticles-loaded PEGylated carbon capsules inside mice model: a step toward clinical application

, , , , &
Pages 577-594 | Received 03 Jan 2019, Accepted 18 Dec 2019, Published online: 13 Jan 2020

References

  • Almeida, J. P. M., A. L. Chen, A. Foster, and R. Drezek. 2011. “In Vivo Biodistribution of Nanoparticles.” Nanomedicine 6 (5): 815–835. doi:10.2217/nnm.11.79.
  • Andersen, A. J., B. Windschiegl, S. Ilbasmis-Tamer, I. T. Degim, A. C. Hunter, T. L. Andresen, and S. M. Moghimi. 2013. “Complement Activation by PEG-Functionalized Multi-Walled Carbon Nanotubes Is Independent of PEG Molecular Mass and Surface Density.” Nanomedicine: Nanotechnology,Biologyand Medicine 9 (4): 469–473. doi:10.1016/j.nano.2013.01.011.
  • Asharani, P., S. Sethu, S. Vadukumpully, S. Zhong, C. T. Lim, M. P. Hande, and S. Valiyaveettil. 2010. “Investigations on the Structural Damage in Human Erythrocytes Exposed to Silver, Gold, and Platinum Nanoparticles.” Advanced Functional Materials 20 (8): 1233–1242. doi:10.1002/adfm.200901846.
  • Augustine, S., J. Singh, M. Srivastava, M. Sharma, A. Das, and B. D. Malhotra. 2017. “Recent Advances in Carbon Based Nanosystems for Cancer Theranostics.” Biomaterials Science 5 (5): 901–952. doi:10.1039/C7BM00008A.
  • Bélanger, M. C., and Y. Marois. 2001. “Hemocompatibility, Biocompatibility, Inflammatory and In Vivo Studies of Primary Reference Materials Low‐Density Polyethylene and Polydimethylsiloxane: A Review.” Journal of Biomedical Materials Research Part Research 58 (5): 467–477. doi:10.1002/jbm.1043.
  • Carnovale, C., G. Bryant, R. Shukla, and V. Bansal. 2017. “Gold Nanoparticle Biodistribution and Toxicity: Role of Biological Corona in Relation with Nanoparticle Characteristics.” Metal Nanoparticles in Pharma Springer 419–436. doi:10.1007/978-3-319-63790-7_18.
  • Chen, N.-T., S.-H. Cheng, J. S. Souris, C.-T. Chen, C.-Y. Mou, and L.-W. Lo. 2013. “Theranostic Applications of Mesoporous Silica Nanoparticles and Their Organic/Inorganic Hybrids.” Journal of Materials Chemistry B 1 (25): 3128–3135. doi:10.1039/c3tb20249f.
  • Chen, F., E. B. Ehlerding, and W. Cai. 2014. “Theranostic Nanoparticles.” Journal of Nuclear Medicine 55 (12): 1919–1922. doi:10.2967/jnumed.114.146019.
  • Cheng, S.-H., C.-H. Lee, M.-C. Chen, J. S. Souris, F.-G. Tseng, C.-S. Yang, C.-Y. Mou, C.-T. Chen, and L.-W. Lo. 2010. “Tri-Functionalization of Mesoporous Silica Nanoparticles for Comprehensive Cancer Theranostics – The Trio of Imaging, Targeting and Therapy.” Journal of Materials Chemistry 20 (29): 6149–6157. doi:10.1039/c0jm00645a.
  • Choi, K. Y., G. Liu, S. Lee, and X. Chen. 2012. “Theranostic Nanoplatforms for Simultaneous Cancer Imaging and Therapy: Current Approaches and Future Perspectives.” Nanoscale 4 (2): 330–342. doi:10.1039/C1NR11277E.
  • Chou, S. W., Y. H. Shau, P. C. Wu, Y. S. Yang, D. B. Shieh, and C. C. Chen. 2010. “In Vitro and In Vivo Studies of FePt Nanoparticles for Dual Modal CT/MRI Molecular Imaging.” Journal of the American Chemical Society 132 (38): 13270–13278. doi:10.1021/ja1035013.
  • de Smet, M., E. Heijman, S. Langereis, N. M. Hijnen, and H. Grüll. 2011. “Magnetic Resonance Imaging of High Intensity Focused Ultrasound Mediated Drug Delivery from Temperature-Sensitive Liposomes: An In Vivo Proof-of-Concept Study.” Journal of Controlled Release 150 (1): 102–110. doi:10.1016/j.jconrel.2010.10.036.
  • Du, D.,. Z. Zou, Y. Shin, J. Wang, H. Wu, M. H. Engelhard, J. Liu, I. A. Aksay, and Y. Lin. 2010. “Sensitive Immunosensor for Cancer Biomarker Based on Dual Signal Amplification Strategy of Graphene Sheets and Multi-Enzyme Functionalized Carbon Nanospheres.” Analytical Chemistry 82 (7): 2989–2995. doi:10.1021/ac100036p.
  • Elmore, S. 2007. “Apoptosis: A Review of Programmed Cell Death.” Toxicologic Pathology 35 (4): 495–516. doi:10.1080/01926230701320337.
  • Elumalai, R., S. Patil, N. Maliyakkal, A. Rangarajan, P. Kondaiah, and A. M. Raichur. 2015. “Protamine-Carboxymethyl Cellulose Magnetic Nanocapsules for Enhanced Delivery of Anticancer Drugs Against Drug Resistant Cancers.” Nanomedicine 11 (4): 969–981. doi:10.1016/j.nano.2015.01.005.
  • Fischer, H. C., and W. C. Chan. 2007. “Nanotoxicity: The Growing Need for In Vivo Study.” Current Opinion in Biotechnology 18 (6): 565–571. doi:10.1016/j.copbio.2007.11.008.
  • Fuertes, A. B., and S. Alvarez. 2004. “Graphitic Mesoporous Carbons Synthesised Through Mesostructured Silica Templates.” Carbon 42 (15): 3049–3055. doi:10.1016/j.carbon.2004.06.020.
  • González-Béjar, M., L. Francés-Soriano, and J. Pérez-Prieto. 2016. “Upconversion Nanoparticles for Bioimaging and Regenerative Medicine.” Frontiers in Bioengineering and Biotechnology 4: 47. doi:10.3389/fbioe.2016.00047.
  • Guo, C., Y. Xia, P. Niu, L. Jiang, J. Duan, Y. Yu, X. Zhou, Y. Li, and Z. Sun. 2015. “Silica Nanoparticles Induce Oxidative Stress, Inflammation, and Endothelial Dysfunction In Vitro via Activation of the MAPK/Nrf2 Pathway and Nuclear Factor-κB Signaling.” International Journal of Nanomedicine 10 (1463). doi:10.2147/IJN.S76114.
  • Hare, J. I., T. Lammers, M. B. Ashford, S. Puri, G. Storm, and S. T. Barry. 2017. “Challenges and Strategies in Anti-Cancer Nanomedicine Development: An Industry Perspective.” Advanced Drug Delivery Reviews 108: 25–38. doi:10.1016/j.addr.2016.04.025.
  • Harper, S., C. Usenko, J. E. Hutchison, B. L. S. Maddux, and R. L. Tanguay. 2008. “In Vivo Biodistribution and Toxicity Depends on Nanomaterial Composition, Size, Surface Functionalisation and Route of Exposure.” Journal of Experimental Nanoscience 3 (3): 195–206. doi:10.1080/17458080802378953.
  • He, L., L. Yang, Y. Duan, L. Deng, X. Sun, Z. Gu, and Z. R. Zhang. 2009. “Cytotoxicity and Hemocompatibility of a Family of Novel MeO-PEG-Poly(D,L-Lactic-co-Glycolic Acid)-PEG-OMe Triblock Copolymer Nanoparticles.” Journal of Applied Polymer Science 113 100: 2933–2944. doi:10.1002/app.22961.
  • Higareda-Almaraz, J. C., I. A. Valtierra-Gutiérrez, M. Hernandez-Ortiz, S. Contreras, E. Hernandez, and S. Encarnacion. 2013. “Analysis and Prediction of Pathways in HeLa Cells by Integrating Biological Levels of Organization with Systems-Biology Approaches.” PLoS One 8 (6): e65433. doi:10.1371/annotation/b212d5e5-7c4b-48c1-80ff.
  • Hu, Y., H. Hu, J. Yan, C. Zhang, Y. Li, M. Wang, W. Tan, J. Liu, and Y. Pan. 2018. “Multifunctional Porous Iron Oxide Nanoagents for MRI and Photothermal/Chemo Synergistic Therapy.” Bioconjugate Chemistry 29 (4): 1283–1290. doi:10.1021/acs.bioconjchem.8b00052.
  • Ilinskaya, A. N., and M. A. Dobrovolskaia. 2013. “Nanoparticles and the Blood Coagulation System. Part II: Safety Concerns.” Nanomedicine 8 (6): 969–981. doi:10.2217/nnm.13.49.
  • Jain, S., T. J. Webster, A. Sharma, and B. Basu. 2013. “Intracellular Reactive Oxidative Stress, Cell Proliferation and Apoptosis of Schwann Cells on Carbon Nanofibrous Substrates.” Biomaterials 34 (21): 4891–4901. doi:10.1016/j.biomaterials.2013.03.055.
  • Joglekar, M., R. A. Roggers, Y. Zhao, and B. G. Trewyn. 2013. “Interaction Effects of Mesoporous Silica Nanoparticles with Different Morphologies on Human Red Blood Cells.” Rsc Advances 3 (7): 2454–2461. doi:10.1039/c2ra22264g.
  • Johnston, H. J., G. R. Hutchison, F. M. Christensen, S. Peters, S. Hankin, K. Aschberger, and V. Stone. 2010. “A Critical Review of the Biological Mechanisms Underlying the In Vivo and In Vitro Toxicity of Carbon Nanotubes: The Contribution of Physico-Chemical Characteristics.” Nanotoxicology 4 (2): 207–246. doi:10.3109/17435390903569639.
  • Kim, J., Y. Piao, and T. Hyeon. 2009. “Multifunctional Nanostructured Materials for Multimodal Imaging, and Simultaneous Imaging and Therapy.” Chemical Society Reviews 38 (2): 372–390. doi:10.1039/B709883A.
  • Krasia-Christoforou, T., and T. K. Georgiou. 2013. “Polymeric Theranostics: Using Polymer-Based Systems for Simultaneous Imaging and Therapy.” Journal of Materials Chemistry B 1 (24): 3002–3025. doi:10.1039/c3tb20191k.
  • Kumar, R., I. Roy, T. Y. Ohulchanskky, L. A. Vathy, E. J. Bergey, M. Sajjad, and P. N. Prasad. 2010. “In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles.” ACS Nano 4 (2): 699–708. doi:10.1021/nn901146y.
  • Lee, J. E., N. Lee, T. Kim, J. Kim, and T. Hyeon. 2011. “Multifunctional Mesoporous Silica Nanocomposite Nanoparticles for Theranostic Applications.” Accounts of Chemical Research 44 (10): 893–902. doi:10.1021/ar2000259.
  • Li, N., J. Alam, M. Venkatesan, A. Eiguren-Fernandez, D. Schmitz, E. Di Stefano, N. Slaughter, et al. 2004. “Nrf2 Is a Key Transcription Factor That Regulates Antioxidant Defense in Macrophages and Epithelial Cells: Protecting Against the Proinflammatory and Oxidizing Effects of Diesel Exhaust Chemicals.” The Journal of Immunology 173 (5): 3467–3481. doi:10.4049/jimmunol.173.5.3467.
  • Li, Y., W. Zhang, J. Niu, and Y. Chen. 2012. “Mechanism of Photogenerated Reactive Oxygen Species and Correlation with the Antibacterial Properties of Engineered Metal-Oxide Nanoparticles.” ACS Nano 6 (6): 5164–5173. doi:10.1021/nn300934k.
  • Lin, Y.-S., and C. L. Haynes. 2009. “Synthesis and Characterization of Biocompatible and Size-Tunable Multifunctional Porous Silica Nanoparticles.” Chemistry of Materials 21 (17): 3979–3986. doi:10.1021/cm901259n.
  • Litvack, M. L., M. Post, and N. Palaniyar. 2011. “IgM Promotes the Clearance of Small Particles and Apoptotic Microparticles by Macrophages.” PLoS One 6 (3): e17223. doi:10.1371/journal.pone.0017223.
  • Love, S. A., M. A. Maurer-Jones, J. W. Thompson, Y.-S. Lin, and C. L. Haynes. 2012. “Assessing Nanoparticle Toxicity.” Annual Review of Analytical Chemistry 5 (1): 181–205. doi:10.1146/annurev-anchem-062011-143134.
  • Lundqvist, M., C. Augustsson, M. Lilja, K. Lundkvist, B. Dahlbäck, S. Linse, and T. Cedervall. 2017. “The Nanoparticle Protein Corona Formed in Human Blood or Human Blood Fractions.” PLoS One 12 (4): e0175871. doi:10.1371/journal.pone.0175871.
  • Mahaling, B., D. A. Srinivasarao, G. Raghu, R. K. Kasam, G. Reddy, and D. Katti. 2018. “A Non-Invasive Nanoparticle Mediated Delivery of Triamcinolone Acetonide Ameliorates Diabetic Retinopathy in Rats.” Nanoscale 10 (35): 16485–16498. doi:10.1039/C8NR00058A.
  • Maldiney, T., C. Richard, J. Seguin, N. Wattier, M. Bessodes, and D. Scherman. 2011. “Effect of Core Diameter, Surface Coating, and PEG Chain Length on the Biodistribution of Persistent Luminescence Nanoparticles in Mice.” ACS Nano 5 (2): 854–862. doi:10.1021/nn101937h.
  • Marcos, F. C., A. G. Felipe, O. F. G. Carla, S. P. Carolina, D. B. Lidiane, K. S. Sangram, P. S. Adelina, et al. 2018. “Toxicological Assessment of PEGylated Single-Walled Carbon Nanotubes in Early Developing Zebrafish.” Toxicology and Applied Pharmacology 347: 54–59. doi:10.1016/j.taap.2018.03.031.
  • Masters, J. R. 2002. “HeLa Cells 50 Years on: The Good, the Bad and the Ugly.” Nature Reviews Cancer 2 (4): 315–319. doi:10.1038/nrc775.
  • Moghimi, S. M. 1997. “Prolonging the Circulation Time and Modifying the Body Distribution of Intravenously Injected Polystyrene Nanospheres by Prior Intravenous Administration of Poloxamine-908. A ‘Hepatic-Blockade’ Event or Manipulation of Nanosphere Surface in Vivo?” Biochimica et Biophysica Acta (Bba) – General Subjects 1336 (1): 1–6. doi:10.1016/S0304-4165(97)00060-3.
  • Motlagh, D., J. Yang, K. Y. Lui, A. R. Webb, and G. A. Ameer. 2006. “Hemocompatibility Evaluation of Poly(Glycerol-Sebacate) In Vitro for Vascular Tissue Engineering.” Biomaterials 27 (24): 4315–4324. doi:10.1016/j.biomaterials.2006.04.010.
  • Nan, X., X. Zhang, Y. Liu, M. Zhou, X. Chen, and X. Zhang. 2017. “Dual-Targeted Multifunctional Nanoparticles for Magnetic Resonance Imaging Guided Cancer Diagnosis and Therapy.” ACS Applied Materials & Interfaces 9: 9986–9995. doi:10.1021/acsami.6b16486.
  • Ndika, J. D. T., J. Sund, H. Alenius, and A. Puustinen. 2018. “Elucidating Differential Nano-Bio Interactions of Multi-Walled Andsingle-Walled Carbon Nanotubes Using Subcellular Proteomics.” Nanotoxicology 12 (6): 554–570. doi:10.1080/17435390.2018.1465141.
  • Owens, D. E., and N. A. Peppas. 2006. “Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles.” International Journal of Pharmaceutics 307: 93–102. doi:10.1016/j.ijpharm.2005.10.010.
  • Paunovska, K., C. D. Sago, C. M. Monaco, W. H. Hudson, M. G. Castro, T. G. Rudoltz, S. Kalathoor, et al. 2018. “A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.” Nano Letters 18 (3): 2148–2157. doi:10.1021/acs.nanolett.8b00432.
  • Peer, D., J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer. 2007. “Nanocarriers as an Emerging Platform for Cancer Therapy.” Nature Nanotechnology 2 (12): 751–760. doi:10.1038/nnano.2007.387.
  • Rammohan, A., G. Mishra, B. Mahaling, L. Tayal, A. Mukhopadhyay, S. Gambhir, A. Sharma, and S. Sivakumar. 2016. “PEGylated Carbon Nanocapsule: A Universal Reactor and Carrier for In Vivo Delivery of Hydrophobic and Hydrophilic Nanoparticles.” ACS Applied Materials & Interfaces 8: 350–362. doi:10.1021/acsami.5b08885.
  • Rattan, R.,. S. Bhattacharjee, H. Zong, C. Swain, M. A. Siddiqui, S. H. Visovatti, Y. Kanthi, S. Desai, D. J. Pinsky, and S. N. Goonewardena. 2017. “Nanoparticle-Macrophage Interactions: A Balance Between Clearance and Cell-Specific Targeting.” Bioorganic & Medicinal Chemistry 25: 4487–4496. doi:10.1016/j.bmc.2017.06.040.
  • Schmohl, K. A., A. Gupta, G. K. Grünwald, M. Trajkovic-Arsic, K. Klutz, R. Braren, M. Schwaiger, et al. 2017. “Imaging and Targeted Therapy of Pancreatic Ductal Adenocarcinoma Using the Theranostic Sodium Iodide Symporter (NIS) Gene.” Oncotarget 8 (20): 33393. doi:10.18632/oncotarget.16499.
  • Schütz, C. A., L. Juillerat-Jeanneret, H. Mueller, I. Lynch, and M. Riediker. 2013. “Therapeutic Nanoparticles in Clinics and under Clinical Evaluation.” Nanomedicine 8 (3): 449–467. doi:10.2217/nnm.13.8.
  • Shanavas, A., S. Sasidharan, D. Bahadur, and R. Srivastava. 2017. “Magnetic Core-Shell Hybrid Nanoparticles for Receptor Targeted Anti-Cancer Therapy and Magnetic Resonance Imaging.” Journal of Colloid and Interface Science 486: 112–120. doi:10.1016/j.jcis.2016.09.060.
  • Shi, J., P. W. Kantoff, R. Wooster, and O. C. Farokhzad. 2017. “Cancer Nanomedicine: Progress, Challenges and Opportunities.” Nature Reviews Cancer 17 (1): 20–37. doi:10.1038/nrc.2016.108.
  • Soppimath, K. S., T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski. 2001. “Biodegradable Polymeric Nanoparticles as Drug Delivery Devices.” Journal of Controlled Release 70 (1-2): 1–20. doi:10.1016/S0168-3659(00)00339-4.
  • Sosale, N. G., K. R. Spinler, C. Alvey, and D. E. Discher. 2015. “Macrophage Engulfment of a Cell or Nanoparticle Is Regulated by Unavoidable Opsonization, a Species-Specific ‘Marker of Self’ CD47, and Target Physical Properties.” Current Opinion in Immunology 35: 107–112. doi:10.1016/j.coi.2015.06.013.
  • Sperling, C., M. Houska, E. Brynda, U. Streller, and C. Werner. 2006. “In Vitro Hemocompatibility of Albumin–Heparin Multilayer Coatings on Polyethersulfone Prepared by the Layer‐by‐Layer Technique.” Journal of Biomedical Materials Research Part A 76: 681–689. doi:10.1002/jbm.a.30519.
  • Valle-Vigón, P., M. Sevilla, and A. B. Fuertes. 2010. “Synthesis of Uniform Mesoporous Carbon Capsules by Carbonization of Organosilica Nanospheres.” Chemistry of Materials 22 (8): 2526–2533. doi:10.1021/cm100190a.
  • Wang, C., S. Ravi, U. S. Garapati, M. Das, M. Howell, J. Mallela, S. Alwarappan, S. S. Mohapatra, and S. Mohapatra. 2013. “Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: A Theranostic Platform for Tumor-Targeted Co-Delivery of Drugs, Genes and MRI Contrast Agents.” Journal of Materials Chemistry B 1 (35): 4396–4405. doi:10.1039/c3tb20452a.
  • Wang, Q., M. Shen, T. Zhao, Y. Xu, J. Lin, Y. Duan, and H. Gu. 2015. “Low Toxicity and Long Circulation Time of Polyampholyte-Coated Magnetic Nanoparticles for Blood Pool Contrast Agents.” Scientific Reports 5 (1): 7774. doi:10.1038/srep07774.
  • Wicki, A., D. Witzigmann, V. Balasubramanian, and J. Huwyler. 2015. “Nanomedicine in Cancer Therapy: Challenges, Opportunities, and Clinical Applications.” Journal of Controlled Release 200: 138–157. doi:10.1016/j.jconrel.2014.12.030.
  • Wolberg, A. S., and R. A. Campbell. 2008. “Thrombin Generation, Fibrin Clot Formation and Hemostasis.” Transfusion and Apheresis Science 38 (1): 15–23. doi:10.1016/j.transci.2007.12.005.
  • Xia, T., M. Kovochich, J. Brant, M. Hotze, J. Sempf, T. Oberley, C. Sioutas, J. I. Yeh, M. R. Wiesner, and A. E. Nel. 2006. “Comparison of the Abilities of Ambient and Manufactured Nanoparticles to Induce Cellular Toxicity according to an Oxidative Stress Paradigm.” Nano Letters 6 (8): 1794–1807. doi:10.1021/nl061025k.
  • Xia, T., M. Kovochich, M. Liong, L. Mädler, B. Gilbert, H. Shi, J. I. Yeh, J. I. Zink, and A. E. Nel. 2008. “Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties.” ACS Nano 2 (10): 2121–2134. doi:10.1021/nn800511k.
  • Yoo, J.-W., E. Chambers, and S. Mitragotri. 2010. “Factors That Control the Circulation Time of Nanoparticles in Blood: challenges, Solutions and Future Prospects.” Current Pharmaceutical Design 16 (21): 2298–2307. doi:10.2174/138161210791920496.
  • Zhao, Y., X. Sun, G. Zhang, B. G. Trewyn, I. I. Slowing, and V. S. Y. Lin. 2011. “Interaction of Mesoporous Silica Nanoparticles with Human Red Blood Cell Membranes: Size and Surface Effects.” ACS Nano 5 (2): 1366–1375. doi:10.1021/nn103077k.
  • Zhao, X., K. Tian, T. Zhou, X. Jia, J. Li, and P. Liu. 2018. “PEGylated Multi-Walled Carbon Nanotubes as Versatile Vector for Tumor-Specific Intracellular Triggered Release with Enhanced Anti-Cancer Efficiency: Optimization of Length and PEGylation Degree.” Colloids and Surfaces B: Biointerfaces 168: 43–49. doi:10.1016/j.colsurfb.2018.02.041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.